Redian新闻
>
DVAX today submtd Marketing Authorization to EU
avatar
DVAX today submtd Marketing Authorization to EU# Stock
s*i
1
http://www.pipelinereview.com/index.php/2012072448524/Vaccines/
BERKELEY, CA, USA I July 24, 2012
DVAX submitted a Marketing Authorization Application (MAA) to the European
Medicines Agency (EMA) pursuing an indication for immunization against
infection caused by all known subtypes of hepatitis B virus in adults 18
through 70 years of age and in patients with chronic kidney disease.
avatar
s*i
2
Its FDA approval date is Feb 2013.
It is cheap to buy it now instead of waiting until too late.
Its 2 doses (in 1 month) immunization offers much convenience comparing to
the conveniential way (3 doses in half a year). I believe it will be
approved.

【在 s******i 的大作中提到】
: http://www.pipelinereview.com/index.php/2012072448524/Vaccines/
: BERKELEY, CA, USA I July 24, 2012
: DVAX submitted a Marketing Authorization Application (MAA) to the European
: Medicines Agency (EMA) pursuing an indication for immunization against
: infection caused by all known subtypes of hepatitis B virus in adults 18
: through 70 years of age and in patients with chronic kidney disease.

avatar
l*i
3
Good. Thanks
avatar
s*i
4
Hope we all gain. :-)

【在 l********i 的大作中提到】
: Good. Thanks
相关阅读
logo
联系我们隐私协议©2024 redian.news
Redian新闻
Redian.news刊载任何文章,不代表同意其说法或描述,仅为提供更多信息,也不构成任何建议。文章信息的合法性及真实性由其作者负责,与Redian.news及其运营公司无关。欢迎投稿,如发现稿件侵权,或作者不愿在本网发表文章,请版权拥有者通知本网处理。